To date, research and development operations have been funded by private and venture capital financing provided in part by:
Home | Technologies | Products | Company Info | News | Investors | Contact Us
Investors

Friedli Corporate Finance

Friedli Corporate Finance was founded by Peter Friedli in 1986 and is one of the leading Swiss Venture Capital firms. Since its inception, Friedli Corporate Finance has invested in over 170 primarily US-based companies in the fields of biotechnology, computer technology, communications and the Internet. Friedli Corporate Finance manages approximately $800 million USD from pension funds, banks and large corporations in Switzerland. It is also the manager of New Venturetec, a public investment company trading on the Swiss Exchange.

 

vSpring Capital

vSpring is an early-stage venture capital fund focusing on investment opportunities in Information Technology and Life Sciences. vSpring capitalizes on the managerial skills and operating experience of its principals to successfully invest in and mentor early-stage companies. vSpring has offices in Salt Lake City, Utah, and Los Alamos, New Mexico.

© Copyright 2004. Inflabloc Pharmaceuticals, Inc.. All Rights Reserved.